Dj. Collison et al., Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques, INV OPHTH V, 41(9), 2000, pp. 2633-2641
PURPOSE. Activation of muscarinic receptors has been implicated in an incre
ased risk of cataract after anticholinesterase treatment for glaucoma. The
purpose of the present study was to determine the acetylcholine muscarinic
receptor subtype(s) present in native human lens epithelial cells (NHLECs)
and a human lens cell line, HLE-B3, and to compare the distribution in othe
r ocular cells.
METHODS. Human lens cells were perfused with artificial aqueous humor (35 d
egrees C) after fura-2 incorporation, and calcium levels were measured usin
g a fluorometric single-cell digital imaging system. Acetylcholine was the
primary muscarinic agonist, and the receptor subtypes were elucidated by de
termining the relative effectiveness of pirenzepine and AF-DX 384 in blocki
ng the agonist-induced response. The levels of expression of mRNA for the r
eceptor subtypes M1 through M5 were determined by quantitative reverse tran
scription-polymerase chain reaction (QRT-PCR) using a sequence detection sy
stem (ABI Prism 7700; Perkin-Elmer, Foster City, Ci). This was performed us
ing total RNA extracted from native lens, retina, iris, and sclera and also
cultured lens cells.
RESULTS. Acetylcholine induced a similar concentration-dependent increase i
n peak-amplitude cytosolic calcium in the range 100 nM to 100 mu M in both
native and HLE-B3 cells. However, the kinetics of the response waveforms to
30-second pulses of acetylcholine were different in the two cell types. At
higher concentrations (>1 mu M), a second phase appeared in the HLE-B3 cel
ls that was absent in the NHLEC response. The 50% inhibitory concentration
(IC50) values for blockade of a 1 mu M acetylcholine response by pirenzepin
e and AF-DX 384 were 30 nM and 230 nM, respectively, for NHLECs, and 300 nM
and 92 nM, respectively, for HLE-B3 cells. The QRT-PCR data showed that mo
re than 90% of die total muscarinic receptor mRNA from NHLEC was of M1 orig
in. In the HLE-B3 cells, however, more than 95% of the mRNA was of M3 origi
n. mRNA for M3 was also in greatest abundance In other eye tissues, althoug
h there was a significant contribution from MZ in iris and sclera.
CONCLUSIONS. Both NHLECs and HLE-B3 cells express muscarinic receptors that
produce significant changes in cytosolic calcium in response to acetylchol
ine. Both pharmacologic and QRT-PCR evidence shows that whereas the M1 subt
ype predominates in NHLECs, M3 is the major contributor in HLE-B3 cells. In
all other eve tissues, M3 appears to be the major contributor. These data
should be taken into account when choosing particular models to investigate
cataract mechanisms and also when designing muscarinic agonists to treat g
laucoma.